Inquis Medical, Inc.

Inquis Medical, Inc. is a clinical-stage medical device company based in Redwood City, California, founded in 2019/2020. The company focuses on developing innovative solutions for venous thromboembolic diseases (VTE), such as deep vein thrombosis and pulmonary embolism. Their mission is to enhance the management of VTE through next-generation thrombectomy technologies that prioritize patient safety and procedural efficiency. The flagship product, the AVENTUS Precision Thrombectomy System™, integrates navigation, aspiration, blood return, and proprietary tissue-sensing technology called TrueClot™. This system allows for real-time feedback on tissue composition, improving precision during clot removal. Inquis Medical has received FDA 510(k) clearance for this system and is conducting a pivotal clinical trial to evaluate its efficacy for aspiration thrombectomy in patients with acute pulmonary embolism. Inquis Medical collaborates with healthcare providers in vascular medicine, interventional radiology, and cardiology, offering clinical support and device training to optimize treatment protocols. The company has raised approximately $40 million in funding to support its product development and commercialization efforts.

• Employees52
• Founded2019
• Total Funding$40000000